LGALS3 and androgen insensitivity syndrome: Table 3 shows the bivariate analysis of serum galectin-3 level classification and PSCI. The results showed that AIS patients with serum galectin-3 levels > 6.3 ng/mL were more likely to develop PSCI than AIS patients with galectin-3 levels below 6.3 ng/mL (OR = 5.49, p < 0.001).